Melatonin |
Chondrocytes (CHON-001) |
In vitro: Co-culture In vivo: Histological evaluation |
Inhibit PI3K/Akt, JNK, ERK, p38 and MAPK |
Inos↓, COX-2↓, NO↓, PGE2↓ |
(23) |
Resveratrol |
Chondrocytes |
In vitro: Co-culture |
BAX/mitochondrial Cyt-C/Caspase |
COX-2↓, NO↓, PGE2↓ |
(24) |
DHM |
TNF-α-treated chondrocyte and rats |
In vitro: Co-culture In vivo: Histological evaluation |
AMPK/SIRT3/PGC-1α |
Mitochondrial fusion↑, antioxidant capacity ↑, ECM balance↑ |
(25) |
Apple procyanidins |
Primary chondrocytes and chondrocyte-specific Sod2−/− mice |
In vitro: Co-culture In vivo: Histological evaluation |
AMPK/SIRT1/PGC-1α |
Integrity of mtDNA↑, mitochondrial biogenesis↑ and proteoglycan biosynthesis↑ |
(26) |
25 μM Zinc |
MIA-treated SW1353 chondrocytes |
In vitro: Co-culture |
PINK1-Mitophagy PI3K/Akt/Nrf2 |
Mitophagy↑, oxidative stress ↓ |
(27) |
SIRT3 activator |
Human and mouse chondrocytes; C57BL/6 male mice |
In vitro: Co-culture In vivo: Histological evaluation |
AMPK/SIRT3/SOD2 |
Integrity of mtDNA4977↑ |
(28) |
Quercetin |
Chondrocytes from 1-week-old Sprague Dawley rats; OA rats. |
In vitro: Co-culture In vivo: Histological evaluation |
AMPK/SIRT1; Inhibit caspase-3 |
NO↓, MMP-3↓, MMP-13↓ and apoptosis↓ |
(29) |
Puerarin |
MIA-treated OA rats |
In vivo: Histological evaluation |
AMPK/PGC-1α |
Mitochondrial biogenesis↑ |
(30) |
LRWXG |
ACLT-treated rats |
In vivo: Histological evaluation |
BAX/mitochondrial Cyt-C/Caspase |
Bcl-2↑, MMP-3↓ and MMP-13↓ |
(31) |
Ginsenoside Rg1 |
IL-1β-treated chondrocytes |
In vitro: Co-culture |
PI3K/Art |
Caspase-3↓, TIMP-1↑, MMP-13↓ and Bcl-2↑ |
(32) |
CS |
H2O2-treated chondrocytes |
In vitro: Co-culture |
Increase MMP |
MMP↑, Caspase-3↓ and Caspase-9↓ |
(33) |
200 μM taurine |
H2O2-induced chondrocytes |
In vitro: Co-culture |
Regulate Nrf2, miR-146a and miR-34a |
Bcl-2↑, BAX↓ |
(34) |
DADS |
C2812 chondrocytes |
In vitro: Co-culture |
Enhance Nrf2 |
GPx1↑, GPx3↑, GPx4↑, CAT↑, SOD1↑, BAX/Bcl-2↓ and Caspase-3↓ |
(35) |